Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | CTSK | P43235 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.35 |
| ▸ | RELA | Q04206 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | BRD4 | O60885 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31195159 | 0.81 | ADORA1 (0.48) | GLAADORA1MEN1KMT2AGPR119 | |
| SCHEMBL28213798 | 0.78 | TSHR (0.40) | GLAALDH1A1LMNASMN1; SMN2MAPK1 | |
| SCHEMBL17942008 | 0.78 | L3MBTL1 (0.38) | MEN1KMT2AGAAALDH1A1LMNA | |
| SCHEMBL14878683 | 0.77 | USP2 (0.39) | MEN1KMT2AGPR119SMN1; SMN2CTSK | |
| SCHEMBL12931062 | 0.75 | ADORA1 (0.53) | GLAADORA1MEN1KMT2AGPR119 | |
| SCHEMBL630338 | 0.74 | ADORA1 (0.49) | GLAADORA1MEN1KMT2AGPR119 | |
| SCHEMBL7899134 | 0.73 | USP2 (0.38) | MEN1KMT2AGPR119ALDH1A1LMNA | |
| SCHEMBL20670426 | 0.73 | GLA (0.42) | GLAADORA1MEN1KMT2AGPR119 | |
| SCHEMBL29099338 | 0.72 | GLA (0.43) | GLAADORA1MEN1KMT2AGPR119 | |
| SCHEMBL6541860 | 0.72 | ADORA1 (0.47) | GLAADORA1MEN1KMT2AGPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010041720-A1 | Compound with growth hormone releasing properties | NOVO NORDISK A/S (DK) | 2001-11-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010041720-A1 | Compound with growth hormone releasing properties | GHRHR, GHSR, PRLHR | GLA 1079/4885ADORA1 544/4885MEN1 200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.